Cargando…
ROR1 regulates chemoresistance in Breast Cancer via modulation of drug efflux pump ABCB1
Chemoresistance is one of the leading causes of mortality in breast cancer (BC). Understanding the molecules regulating chemoresistance is critical in order to combat chemoresistant BC. Drug efflux pump ABCB1 is overexpressed in chemoresistant neoplasms where it effluxes various chemotherapeutic age...
Autores principales: | Fultang, Norman, Illendula, Abhinav, Lin, Jianhuang, Pandey, Manoj K., Klase, Zachary, Peethambaran, Bela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000766/ https://www.ncbi.nlm.nih.gov/pubmed/32020017 http://dx.doi.org/10.1038/s41598-020-58864-0 |
Ejemplares similares
-
Retinoic acid induces differentiation in neuroblastoma via ROR1 by modulating retinoic acid response elements
por: Illendula, Abhinav, et al.
Publicado: (2020) -
Strictinin, a novel ROR1-inhibitor, represses triple negative breast cancer survival and migration via modulation of PI3K/AKT/GSK3ß activity
por: Fultang, Norman, et al.
Publicado: (2019) -
Regulation of cancer stem cells in triple negative breast cancer
por: Fultang, Norman, et al.
Publicado: (2021) -
Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
por: Henry, C E, et al.
Publicado: (2016) -
Correction to: Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
por: Henry, C. E., et al.
Publicado: (2022)